vimarsana.com

Latest Breaking News On - Significantly reduces cardiovascular death - Page 1 : vimarsana.com

Sotagliflozin Improved Outcomes in Patients With and

Late-breaking presentation of analysis of SCORED clinical trial data describes significant reduction in cardiovascular death, myocardial infarction and.

United statesChas schultzCraigb granowitzDeepakl bhattLexicon pharmaceuticalsAmerican college of cardiologyHarvard medical schoolLexicon pharmaceuticals incScience session of the american heart associationExchange commissionCorporate communicationsClinical researchAmerican collegeAnnual scientific sessionInterventional cardiovascular programsSignificantly reduces cardiovascular death

Sotagliflozin Improved Outcomes in Patients With and Without Prior Cardiovascular Disease in New Analysis Presented at the American College of Cardiology s 71st Annual Scientific Session (ACC 22)

02.04.2022 - Late-breaking presentation of analysis of SCORED clinical trial data describes significant reduction in cardiovascular death, myocardial infarction and stroke with sotagliflozin treatment as compared to placeboTHE WOODLANDS, Texas, April 02, 2022 . Seite 1

Craigb granowitzDeepakl bhattClinical researchHarvard medical schoolCardiovascular programsSignificantly reduces cardiovascular deathMyocardial infarctionFeatured clinical

New Analysis of Cardiovascular Endpoints in the SCORED Trial to Be Presented at the American College of Cardiology s 71st Annual Scientific Session (ACC 22)

21.03.2022 - Late-breaking clinical trial presentation by Deepak L. Bhatt, M.D., M.P.H., will describe new analysis of rates of CV death, myocardial infarction and stroke in the SCORED trialTHE WOODLANDS, Texas, March 21, 2022 (GLOBE NEWSWIRE) - Lexicon .

Chas schultzDeepakl bhattExchange commissionLexicon pharmaceuticalsCorporate communicationsEuropean unionClinical researchi sessionHarvard medical schoolInterventional cardiovascular programsSignificantly reduces cardiovascular deathMyocardial infarctionFeatured clinical researchi session

vimarsana © 2020. All Rights Reserved.